REPRODUCTIVE RIGHTS


  • Doctors Say Iowa Abortion Ban Could Worsen OB-GYN Shortage

    Iowa doesn’t have enough maternal health care specialists, and that long-standing problem could get worse if the recently passed six-week abortion ban goes into effect. The ban penalizes doctors for performing abortions if electrical impulses are detected in the fetus. There are limited, vague exceptions for rape, incest, fetal abnormalities that will result in death…


  • First Over-the-Counter Birth Control Pill Gets FDA Approval

    Birth control pills will soon be available over the counter in the United States, after the U.S. Food and Drug Administration (FDA) on Thursday approved the Perrigo Company’s daily birth control medication, Opill, to be sold without a prescription. Opill is the first ever birth control pill to be approved for over-the-counter sales. The medication…


  • Post-Roe Abortion Bans Have Led to Devastating Outcomes for Women, Study Finds

    Women and girls across the United States have suffered devastating experiences over the past year when seeking abortions and routine reproductive health care as a result of  the Supreme Court’s decision to overturn Roe v. Wade last June.  A new study from the University of California San Francisco’s Advancing New Standards in Reproductive Health (ANSIRH),…


  • What the Latest Abortion Pill Ruling Means for You

    UPDATE: Supreme Court Justice Samuel Alito on Friday temporarily delayed Federal Judge Matthew Kacsmaryk’s ruling which sought to suspend the FDA’s approval for the abortion medication mifepristone.  Alito’s ruling means mifepristone remains available according to each state’s abortion laws. The full Supreme Court is expected to rule on whether to uphold or overturn Kacsmaryk’s decision on…


  • Judge’s Abortion Pill Ruling Could Have Widespread Consequences On Health Care Access

    Two judges—one in Texas, and one in Washington—issued competing rulings on the fate of the abortion medication mifepristone on Friday, throwing the future of access to the pill into question. U.S. District Judge Matthew Kacsmaryk, a Trump appointee, ordered a hold on the federal approval of mifepristone, in what multiple publications have said overruled decades…